Bortezomib Combined with Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone (R-VFND) for the Treatment of Relapsed/Refractory Follicular Lymphoma

Anne W Beaven^*, Anthony D Sung, David Rizzieri and Zhiguo Li

Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA, E-mail: anne.beaven@duke.edu

^*Corresponding Author: Anne W Beaven, Anne W Beaven, Duke University Medical Center, Durham, NC, USA, Tel: 919-684-8964, Fax: 919-684-5325 Email: